Zoetis Inc. $ZTS Shares Purchased by Integrated Advisors Network LLC

Integrated Advisors Network LLC grew its stake in shares of Zoetis Inc. (NYSE:ZTS) by 22.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 34,829 shares of the company’s stock after buying an additional 6,342 shares during the period. Integrated Advisors Network LLC’s holdings in Zoetis were worth $5,096,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. Clifford Swan Investment Counsel LLC purchased a new stake in shares of Zoetis in the third quarter valued at $3,460,000. Interchange Capital Partners LLC purchased a new stake in Zoetis during the 3rd quarter worth about $209,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Zoetis by 14.6% in the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,312,779 shares of the company’s stock valued at $631,046,000 after purchasing an additional 550,859 shares during the last quarter. Montrusco Bolton Investments Inc. lifted its holdings in Zoetis by 23.3% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 607,764 shares of the company’s stock valued at $88,928,000 after purchasing an additional 114,912 shares in the last quarter. Finally, AlphaCore Capital LLC lifted its holdings in Zoetis by 125.0% in the 3rd quarter. AlphaCore Capital LLC now owns 3,575 shares of the company’s stock valued at $523,000 after purchasing an additional 1,986 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. lowered their price target on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a report on Wednesday, November 5th. BTIG Research restated a “buy” rating and set a $160.00 target price on shares of Zoetis in a research report on Thursday. Weiss Ratings cut shares of Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, January 28th. Piper Sandler reiterated a “neutral” rating and issued a $135.00 price target (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. Finally, Bank of America raised their price objective on Zoetis from $135.00 to $140.00 and gave the stock a “neutral” rating in a report on Friday, February 13th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $152.91.

Zoetis Stock Performance

NYSE:ZTS opened at $129.65 on Friday. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. The company has a market cap of $54.73 billion, a P/E ratio of 21.54, a P/E/G ratio of 1.97 and a beta of 0.96. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.00. The firm’s 50 day moving average is $125.88 and its two-hundred day moving average is $134.28.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. The ex-dividend date is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 1.6%. Zoetis’s dividend payout ratio is currently 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.